Multigenic human hypertension: evidence for subtypes and hope for haplotypes

Area of Science:

• Genetics
• Cardiovascular Disease
• Human Physiology

Background:

• Early-onset hypertension (before age 60) shows strong familial aggregation, primarily driven by genetic factors.
• Hypertension is a complex condition with heterogeneous pathophysiological mechanisms, including dyslipidemia, obesity, and cation metabolism.

Purpose of the Study:

• To investigate the genetic underpinnings of early-onset hypertension.
• To identify intermediate phenotypes that link specific genes to hypertension susceptibility.
• To explore the combined influence of polygenic background and environmental factors on essential hypertension.

Main Methods:

• Analysis of highly heritable traits (e.g., sodium-lithium countertransport, urinary kallikrein excretion, body fat pattern index) for major gene segregation.
• Genetic linkage studies to identify susceptibility loci (e.g., HLA, MN blood group, haptoglobin).
• DNA sequencing to detect mutations (e.g., lipoprotein lipase) associated with dyslipidemic hypertension.

Main Results:

• Highly heritable traits serve as intermediate phenotypes, demonstrating measurable contributions of single genes to hypertension susceptibility.
• Specific genetic loci and mutations, such as in lipoprotein lipase, are linked to lipid abnormalities and potentially hypertension.
• Family studies, particularly with multiple affected siblings, are crucial for dissecting genetic and environmental contributions.

Conclusions:

• Genetic factors play a predominant role in early-onset familial hypertension.
• Identifying intermediate phenotypes and specific gene variants advances our understanding of hypertension's complex etiology.
• This genetic insight promises more personalized and effective hypertension management strategies.